UCP2 and cardiovascular disorder: To determine ifUCP1, UCP2, andUCP3mRNA and protein expression levels were a potential source of cardiovascular disease, we analyzed these levels in EAT and MAT obtained from the CAD and the control group.Figure 2, displaying the levels of mRNA expression (in median [minimum-maximum] values), shows a higher expression ofUCP1mRNA in EAT of patients with CAD versus controls (74.2 [6.6-179.1] versus 24.4 [9.9-100.9], respectively; p = 0.001).